Filing Details

Accession Number:
0001209191-12-014711
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-01 19:32:09
Reporting Period:
2012-02-28
Filing Date:
2012-03-01
Accepted Time:
2012-03-01 19:32:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411861 Mako Surgical Corp. MAKO Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 201901148
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1433586 H Duncan Moffat C/O Mako Surgical Corp.
2555 Davie Road
Ft. Lauderdale FL 33317
Svp Of Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-28 6,300 $7.94 24,207 No 4 M Direct
Common Stock Disposition 2012-02-28 6,300 $40.00 17,907 No 4 S Direct
Common Stock Acquisiton 2012-02-29 12,800 $7.94 30,707 No 4 M Direct
Common Stock Disposition 2012-02-29 12,800 $40.02 17,907 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-02-28 6,300 $0.00 6,300 $7.94
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-02-29 12,800 $0.00 12,800 $7.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
68,488 2018-04-28 No 4 M Direct
55,688 2018-04-28 No 4 M Direct
Footnotes
  1. The exercise and sales reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2011.
  2. The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $40.05 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
  3. The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $40.12 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
  4. Vests and becomes exercisable ratably quarterly over four years commencing on the grant date.